OncoSec Selected to Present Data at Upcoming Head and Neck Cancer Conferences Mar 22, 2012 6:01am EDT
Co-Principal Investigator for OncoSec's Phase II Merkel Cell Carcinoma Study to Speak at 70th Annual American Academy of Dermatology Meeting Mar 19, 2012 6:01am EDT
OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial Mar 14, 2012 6:01am EDT
OncoSec to Evaluate Potential Predictive or Prognostic Biomarkers for Treatment of Solid Tumor Cancers Using OMS ElectroImmunotherapy Mar 08, 2012 6:01am EST
OncoSec's OMS ElectroImmunotherapy Technology Platform and its Ongoing Phase II Merkel Cell Carcinoma Clinical Trial Featured in Seattle Newspaper Mar 07, 2012 6:01am EST
OncoSec's OMS ElectroOncology Technology Platform Featured in Medical Device & Diagnostic Industry Feb 29, 2012 6:01am EST
OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma Feb 28, 2012 6:01am EST
